Your session is about to expire
← Back to Search
Nasal Congestion Relief Device
Sonu Treatment Group for Nasal Congestion and Inflammation (SCORE Trial)
N/A
Waitlist Available
Led By Jacob Johnson, MD
Research Sponsored by Third Wave Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Present with symptoms of nasal congestion for 1 month or more prior to treatment
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights
SCORE Trial Summary
This trial tested a drug to treat severe stuffy nose and found it to be safe & effective.
Eligible Conditions
- Nasal Congestion and Inflammation
SCORE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You have experienced a prolonged bout of nasal congestion prior to commencing treatment.
SCORE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Effectiveness
Secondary outcome measures
Secondary Effectiveness
SCORE Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Sonu Treatment GroupExperimental Treatment1 Intervention
Patients will receive acoustic resonance therapy for 15 minutes, twice a day, for two weeks using Sonu.
Group II: Sham Control GroupPlacebo Group1 Intervention
Patients will receive non-resonant acoustic energy for 15 minutes, twice a day, for two weeks using Sonu.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sonu
2022
N/A
~60
Find a Location
Who is running the clinical trial?
Third Wave TherapeuticsLead Sponsor
3 Previous Clinical Trials
325 Total Patients Enrolled
Jacob Johnson, MDPrincipal InvestigatorSan Francisco Otolaryngology Medical Group
4 Previous Clinical Trials
341 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You experience at least two hours of nasal congestion within a 24 hour period.You have a history of growths or masses in your nose.You must be at least 18 years of age to participate in this study.You have experienced a prolonged bout of nasal congestion prior to commencing treatment.You had a sinus infection or used certain nose medications in the last month.
Research Study Groups:
This trial has the following groups:- Group 1: Sham Control Group
- Group 2: Sonu Treatment Group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this research project require additional volunteers?
"Affirmative. Clinicaltrials.gov reports that this trial, initially posted on March 23rd 2022, is actively searching for participants. 50 volunteers are required from 1 designated medical centre."
Answered by AI
How many participants are being treated as part of this research project?
"Affirmative. Records hosted on clinicaltrials.gov demonstrate that registration for this medical experiment, which was initially posted on March 23rd 2022, is in progress. Around 50 participants need to be enrolled from 1 centre."
Answered by AI
Who else is applying?
What site did they apply to?
San Francisco Otolaryngology Medical Group
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger